New HPV Vaccine Approved for Use in Europe
PHILADELPHIA, PA —This week, top drug maker GlaxoSmithKline announced that its HPV-prevention vaccine Cervarix has been approved for use by the European Commission in 27 countries.GlaxoSmithKline has also submitted Cervarix to the U.S. FDA for approval in the states....
Posted On 26 Sep 2007